Citicoline (CDP-Choline)
Cytidine-5'-diphosphocholine
TL;DR
A source of choline plus cytidine (converted to uridine) that supports acetylcholine synthesis and neuronal membrane repair. One of the better-evidenced nootropics, with human trial data in mild cognitive impairment and vascular cognitive decline. Well tolerated at 250-500 mg/day.
Ideal For
- Older adults noticing memory decline
- People seeking a non-stimulant focus adjunct
- Low dietary choline intake (few eggs, little meat)
- Stacking with racetams or caffeine, where choline demand rises
Avoid If
- Bipolar disorder in manic phase (theoretical dopaminergic effect)
- Hypotension — rare reports of blood pressure lowering
- History of tension headache triggered by cholinergics
Frequently Asked Questions
Overview
Citicoline (CDP-choline) delivers two useful molecules: choline, the precursor for the memory neurotransmitter acetylcholine, and cytidine, which the body converts to uridine — a building block for phosphatidylcholine in neuronal membranes. It is sold as a drug in parts of Europe and Asia for stroke recovery and cognitive impairment. Trials in mild cognitive impairment and vascular dementia show modest but consistent memory benefits over 6-12 weeks, making it one of the few nootropics with meaningful human data rather than extrapolated animal findings.
How It Works
- Supplies choline for acetylcholine synthesis via choline acetyltransferase
- Cytidine is converted to uridine, supporting phosphatidylcholine synthesis through the Kennedy pathway
- Stabilises neuronal membranes and may support synaptic density
- Mild dopaminergic and noradrenergic effects may explain subtle alerting
Quick Facts
- Provides both choline and uridine precursors
- Used as a prescription drug for cognitive impairment in some countries
- Memory benefits in trials emerged over 6-12 weeks, not acutely
- Standard dose: 250-500 mg/day; trials used up to 2 g/day
- Commonly stacked with caffeine or omega-3
Benefits & Outcomes
Executive Function
A defensible choice, especially with ageing or attentional complaints.
Verbal Fluency
Citicoline shows modest attention and language benefits in impaired populations.
Processing Speed Improvement
Citicoline shows some attention and speed benefit in older adults, less so in healthy young people.
Cerebral Infarction Volume
Citicoline showed neuroprotection promise, but a large trial found no benefit for limiting stroke damage.
Neuroplasticity Enhancement
Reasonable support for attention and membrane synthesis; plasticity claims outrun the data.
Synaptic Plasticity
Citicoline supports membrane phospholipid synthesis with modest cognitive trial support.
Learning Speed Increase
Citicoline improves attention, which supports learning indirectly rather than accelerating acquisition itself.
Acetylcholine Enhancement
Citicoline reliably raises choline availability for acetylcholine synthesis — this is the mechanism it is best characterised for.
Increased Energy Production
Citicoline improves brain energy metabolism markers, but it is not an energy supplement in the everyday sense.
Neuroprotection
Citicoline has the deepest neuroprotection dataset of any widely available nootropic, built on decades of stroke and vascular cognitive impairment research.
Enhanced Memory Formation
Supports memory formation through cholinergic transmission and membrane synthesis, with the clearest effects in older adults.
Health Concerns Addressed
Brain Fog
One of the better-supported options for genuine brain fog, with human trials in healthy adults rather than only in dementia populations.
Memory Loss
Reasonable evidence for age-associated memory lapses in adults over 50; weaker for young healthy memory.
Supporting Research20 studies
Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Nakazaki E, Mah E, Sanoshy K +2 more
Citicoline supplementation for 12 weeks improved memory function in cognitively healthy older adults.
Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage
Bruce SE, et al.
Overall, these findings suggest that the beverage significantly improved sustained attention, cognitive effort and reaction times in healthy adults.
Citicoline in acute ischemic stroke: A randomized controlled trial
et al
We did not find any significant difference between the Citicoline or placebo arms with respect to either our primary or secondary outcomes.
Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review
Que DS, Jamora RDG
Citicoline allowed effective reduction of levodopa by up to 50%.
Application of Citicoline in Neurological Disorders: A Systematic Review
Citicoline has been used across neurological disorders, with inconsistent results in traumatic brain injury.
Citicoline for cognitive and processing-speed impairment: a systematic review and meta-analysis
Fioravanti M, Buckley AE
Citicoline produced significant improvements in memory and behaviour, with weaker effects on processing speed
Citicoline (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly (Cochrane Review)
Fioravanti M, Yanagi M
There is some evidence that CDP-choline has a positive effect on memory and behaviour in older people with mild-to-moderate cognitive impairment.
Citicoline and membrane phospholipid synthesis in the human brain: a review
Wurtman RJ, Cansev M, Ulus IH
Citicoline increased brain phosphatide levels and dendritic spine density
Citicoline supplementation and cognitive performance in healthy adults: a randomized double-blind trial
Nakazaki E, Mah E, Sanoshy K +2 more
Citicoline improved composite memory and learning scores relative to placebo over 12 weeks
Citicoline-Amantadine Trial in Traumatic Brain Injury: A Prospective Randomized Study
Citicoline and amantadine improved arousal and behavioural outcomes in the early phase of moderate traumatic brain injury.
The Effect of Oral Citicoline and Docosahexaenoic Acid on the Visual Field of Patients with Glaucoma: A Randomized Trial
Anton A, Garcia V, Munoz M +2 more
The role of nutraceuticals in the treatment of glaucoma remains controversial.
The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males
McGlade E, Agoston AM, DiMuzio J +4 more
Citicoline improved attention and psychomotor speed and reduced impulsivity relative to placebo.
Citicoline and brain phospholipid synthesis in humans: a magnetic resonance spectroscopy study
Silveri MM, Dikan J, Ross AJ +3 more
Citicoline increased brain phosphocreatine and membrane phospholipid synthesis markers
Citicoline and verbal memory in older adults with memory complaints: randomized trial
Spiers PA, Myers D, Hochanadel GS +2 more
Citicoline improved delayed verbal recall in participants with poorer baseline memory
Citicoline on the Barthel Index: Severe and moderate brain injury
Citicoline improved Glasgow Coma Scale and functional outcomes compared with placebo after brain injury.
Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke
Alvarez-Sabín J, Santamarina E, Maisterra O +3 more
Patients treated long-term with citicoline showed better attention-executive scores and quality of life at 2 years.
Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials
Secades JJ, Alvarez-Sabín J, Castillo J +4 more
Pooled analysis suggested a small increase in the odds of global recovery with citicoline.
Citicoline for treating people with acute ischemic stroke (Cochrane Review)
Martí-Carvajal AJ, Valli C, Martí-Amarista CE +3 more
Citicoline probably results in little to no difference in functional recovery or mortality after acute ischemic stroke.
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
Dávalos A, Alvarez-Sabín J, Castillo J +9 more
Citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke.
Use of Citicoline in Attention-Deficit/Hyperactivity Disorder: A Pilot Study
Hübner IB, Scheibe DB, Marchezan J +1 more
As a result, no statistically significant difference was noted between the use of citicoline and placebo in the evaluated parameters.
Safety Information
Potential Side Effects
{"Headache (most common)","Insomnia with evening or high dosing","Mild GI upset","Vivid dreams (uncommon)"}
Contraindications
None well-established
Drug Interactions
- Levodopa
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
250-500 mg
Best Time to Take
Morning with or without food
Best Form
Citicoline (Cognizin)
Bioavailability
Nearly complete oral bioavailability; hydrolysed to choline and cytidine, which cross the blood-brain barrier before recombining.
Dosing by Goal
| Goal | Dose | Notes |
|---|---|---|
| General cognitive support | 250-500 mg once daily | Morning, with or without food. Start at 250 mg — some users report headache at higher starting doses. |
| Cognitive impairment (trial dosing) | 1000-2000 mg daily | Doses used in vascular dementia and MCI trials; clinician supervision advised. |
Forms Compared
Citicoline (CDP-choline)
Best for Memory support, age-related cognitive concerns
The standard, well-studied form. Brand versions (e.g. Cognizin) match the trial material.
Alpha-GPC (comparison)
Best for Acute choline delivery, power output
Not citicoline, but the main alternative. Delivers more choline per mg; lacks the uridine component and has weaker long-term trial data.
Food & Timing
Morning; evening dosing can cause insomnia in sensitive users.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.